Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.
about
Management of chronic airway diseases: What can we learn from real-life data?The respiratory threat posed by multidrug resistant Gram-negative bacteria.Bronchiectasis: Phenotyping a Complex Disease.The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know?Comorbidities in adults with asthma: Population-based cross-sectional analysis of 1.4 million adults in Scotland.Sputum Neutrophil Elastase as a Biomarker for Disease Activity in Bronchiectasis.The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.Patient participation in ERS guidelines and research projects: the EMBARC experienceSensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPDLatin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts.Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.Neurological and Sleep Disturbances in Bronchiectasis.Profile of the ProAxsis active neutrophil elastase immunoassay for precision medicine in chronic respiratory disease.Aspergillus fumigatus Detection and Risk Factors in Patients with COPD-Bronchiectasis Overlap.The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis.The pharmacological treatment of bronchiectasis.Arterial stiffness in adults with steady-state bronchiectasis: association with clinical indices and disease severity.Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease.Patient information, education and self-management in bronchiectasis: facilitating improvements to optimise health outcomes."The missing ingredient": the patient perspective of health related quality of life in bronchiectasis: a qualitative study.Non-cystic fibrosis bronchiectasis in the elderly: current perspectivesWhy, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasisGet together to increase awareness in bronchiectasis: a report of the 2 World Bronchiectasis Conference
P2860
Q36312040-ED337617-ADA6-483D-84BA-3CE5BE59639BQ38662137-F3386FB9-CBBF-4094-A8B5-5BE516A74A53Q38901227-F179C582-D256-4177-8755-6DF3F61269A9Q39402027-84C35854-3A6C-4D39-B51C-D7BADE0C2E8FQ40139808-9D397529-A87C-40AE-BF69-733EA7D49848Q40201405-2E435E61-72E6-40DB-B4DA-A9E7C5D15303Q41615902-5FEE54CE-266A-4BAB-B388-0E66D1A83868Q41615965-77F2D45D-BE87-4F7A-BC1C-FB40FBB5C18CQ41632970-C6A97596-C403-4843-99AA-8E914C05FDF1Q42248571-A0D4A836-4982-4979-9740-79641ADE7863Q42368136-B7C644BC-C643-447B-A8D3-D86AFD7A8E22Q47299683-319FB7AF-167D-470F-97A6-DB70E64EB9B2Q47788593-C675CB87-06D6-406B-9517-19A2C3639EC2Q50099861-5F61AAA0-2E81-4CEE-BD9C-8033A1420CD4Q50532047-4A4AC8F3-E4C2-4671-A07B-26544DBCFE4AQ51751531-0767032D-8D54-4F11-B2D2-CB2FC8A04929Q53823795-B3628D09-8A80-4B9B-A722-ADE4F09962E4Q54965235-243423FE-8ADB-432E-A20D-6F180F4E5B03Q55048565-090F8D9C-9ADF-41C9-9A9A-7233B526F0C4Q55331902-C6DF0F78-820F-428F-A717-A4BE9C3D47D7Q55350869-15DE612D-3678-441E-B9FE-25745D8EBF44Q57646591-86805067-6C4A-4BF5-952F-CB0F660AE3BBQ58792961-5779DF73-D74A-4BD9-8AE4-2536858CDAE8Q58792964-C7BBAD4C-D3A5-4AD2-91B7-5D56D0D68F78
P2860
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Comorbidities and the risk of ...... onal multicentre cohort study.
@en
Comorbidities and the risk of ...... onal multicentre cohort study.
@nl
type
label
Comorbidities and the risk of ...... onal multicentre cohort study.
@en
Comorbidities and the risk of ...... onal multicentre cohort study.
@nl
prefLabel
Comorbidities and the risk of ...... onal multicentre cohort study.
@en
Comorbidities and the risk of ...... onal multicentre cohort study.
@nl
P2093
P2860
P50
P1476
Comorbidities and the risk of ...... ional multicentre cohort study
@en
P2093
Alberto Pesci
Anthony De Soyza
Dusan Skrbic
James D Chalmers
Lieven J Dupont
Marcos I Restrepo
Melissa J McDonnell
Michael R Loebinger
Pieter C Goeminne
Robert M Rutherford
P2860
P304
P356
10.1016/S2213-2600(16)30320-4
P577
2016-11-16T00:00:00Z